212 related articles for article (PubMed ID: 1322782)
1. Incidence of ras oncogene activation in lung carcinomas in Hong Kong.
Lung ML; Wong M; Lam WK; Lau KS; Kwan S; Fu KH; Cheung H; Yew WW
Cancer; 1992 Aug; 70(4):760-3. PubMed ID: 1322782
[TBL] [Abstract][Full Text] [Related]
2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
3. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma].
Cui Q; Wang Z; Chen J; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596
[TBL] [Abstract][Full Text] [Related]
4. Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients.
Ko JM; Cheung MH; Wong CM; Lau KW; Tang CM; Kwan MW; Lung ML
Cancer Lett; 1998 Dec; 134(2):169-76. PubMed ID: 10025877
[TBL] [Abstract][Full Text] [Related]
5. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
Tam IY; Chung LP; Suen WS; Wang E; Wong MC; Ho KK; Lam WK; Chiu SW; Girard L; Minna JD; Gazdar AF; Wong MP
Clin Cancer Res; 2006 Mar; 12(5):1647-53. PubMed ID: 16533793
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer.
Nishio H; Nakamura S; Horai T; Ikegami H; Matsuda M
Cancer; 1992 Mar; 69(5):1130-6. PubMed ID: 1310887
[TBL] [Abstract][Full Text] [Related]
8. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.
Li S; Rosell R; Urban A; Font A; Ariza A; Armengol P; Abad A; Navas JJ; Monzo M
Lung Cancer; 1994 Jul; 11(1-2):19-27. PubMed ID: 8081702
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific detection of K-ras oncogene expression in human non-small-cell lung carcinomas.
Slebos RJ; Habets GG; Evers SG; Mooi WJ; Rodenhuis S
Int J Cancer; 1991 Apr; 48(1):51-6. PubMed ID: 1850383
[TBL] [Abstract][Full Text] [Related]
10. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
11. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
12. K-ras gene mutations in non-small cell lung cancer in Japanese.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2001; 8(4):889-92. PubMed ID: 11410804
[TBL] [Abstract][Full Text] [Related]
13. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.
Slebos RJ; Hruban RH; Dalesio O; Mooi WJ; Offerhaus GJ; Rodenhuis S
J Natl Cancer Inst; 1991 Jul; 83(14):1024-7. PubMed ID: 2072410
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.
Graziano SL; Gamble GP; Newman NB; Abbott LZ; Rooney M; Mookherjee S; Lamb ML; Kohman LJ; Poiesz BJ
J Clin Oncol; 1999 Feb; 17(2):668-75. PubMed ID: 10080613
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
16. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.
Rodenhuis S; van de Wetering ML; Mooi WJ; Evers SG; van Zandwijk N; Bos JL
N Engl J Med; 1987 Oct; 317(15):929-35. PubMed ID: 3041218
[TBL] [Abstract][Full Text] [Related]
17. Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung.
Urban T; Ricci S; Lacave R; Antoine M; Kambouchner M; Capron F; Bernaudin JF
Br J Cancer; 1996 Oct; 74(7):1051-5. PubMed ID: 8855973
[TBL] [Abstract][Full Text] [Related]
18. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris].
Liu XF
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668
[TBL] [Abstract][Full Text] [Related]
19. Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive method.
Keohavong P; Zhu D; Melacrinos AC; DeMichele MA; Weyant RJ; Luketich JD; Testa JR; Fedder M; Siegfried JM
Int J Cancer; 1997 Apr; 74(2):162-70. PubMed ID: 9133449
[TBL] [Abstract][Full Text] [Related]
20. Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction.
Husgafvel-Pursiainen K; Ridanpää M; Hackman P; Anttila S; Karjalainen A; Onfelt A; Børresen AL; Vainio H
Environ Health Perspect; 1992 Nov; 98():183-5. PubMed ID: 1486847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
